Clinical Trials associated with HSP70 heat-shock proteins x DUSP1
ChiCTR2400088173
/ SuspendedEarly Phase 1IIT
A randomized controlled trial of csDMARDs combined with Tripterygium glycoside tablets in the treatment of rheumatoid arthritis
Start Date01 Sep 2024
Sponsor / Collaborator-
NCT02044952
/ Unknown statusPhase 2/3IIT
Prospective Experimental of Tripterygium Glycoside in the Treatment of Crohn's Disease for Induction Remission
The purpose of this study is to assess the effect and safety of Tripterygium Glycosides in the treatment of Crohn's disease for induction remission and compare the therapeutic effect with patients who received mesalazine.
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.